Epstein-barr virusIntervention2 papersIn silico1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 2Oct 2026: 02Ageing Research ReviewsReview·1 OctLifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancyThe Lancet OncologyIn silico·29 SepGlobal burden of cancer attributable to infections in 2024: a worldwide incidence analysis
Ageing Research ReviewsReview·1 OctLifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy
The Lancet OncologyIn silico·29 SepGlobal burden of cancer attributable to infections in 2024: a worldwide incidence analysis